OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer

There is strong interest in targeting the androgen receptor (AR) in estrogen receptor (ER) positive breast cancer, but widespread confusion exits as to what therapeutic strategy - agonism or antagonism - is appropriate. Current understanding of AR predominantly stems from the field of prostate cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickey, Theresa E, Selth, Luke, Chia, Kee Ming, Milioli, Heloisa, Roden, Daniel, Laven-Law, Geraldine, Jindal, Shalini, Hui, Mun, Ebrahimie, Esmaeil, birrell, Stephen, Stelloo, Suzan, Caldon, Elizabeth, Findlay-Schultz, Jessica, Abdel_Fatah, Tarek, Ellis, Ian, Zwart, Wilbert, Palmieri, Carlo, Sartorius, Carol Ann, Swarbrick, Alex, Lim, Elgene, Carroll, Jason S, Tilley, Wayne D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209210/
http://dx.doi.org/10.1210/jendso/bvaa046.982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209210/
http://dx.doi.org/10.1210/jendso/bvaa046.982

Ejemplares similares